Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jianru Xiao"'
Autor:
Da Wang, Fanrong Liu, Binbin Li, Jinhui Xu, Haiyi Gong, Minglei Yang, Wei Wan, Jian Jiao, Yujie Liu, Jianru Xiao
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 7, p 2521 (2023)
Background: Primary pelvis and spine osteosarcoma (PSOS) is a specific type of osteosarcoma that is difficult to treat and has a poor prognosis. In recent years, the research on osteosarcoma has been increasing, but there have been few studies on PSO
Externí odkaz:
https://doaj.org/article/b807452c99b5429689e13a5093200ced
Autor:
Aimin Jiang, Juelan Ye, Ye Zhou, Baohua Zhu, Juan Lu, Silun Ge, Le Qu, Jianru Xiao, Linhui Wang, Chen Cai
Publikováno v:
Cells, Vol 12, Iss 3, p 349 (2023)
Background: Progress in the diagnosis and treatment of clear cell renal cell carcinoma (ccRCC) has significantly prolonged patient survival. However, ccRCC displays an extreme heterogenous characteristic and metastatic tendency, which limit the benef
Externí odkaz:
https://doaj.org/article/648230e71c7a4ffeb6128471f19a5be0
Autor:
Lijun Jiang, Jie Luo, Haiyi Gong, Fei Zhang, Linxiang Zhang, Linfei Cheng, Xin Gao, Dan Zhang, Tielong Liu, Jianru Xiao
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 1, p 355 (2023)
(1) Background: Primary intraspinal tumors account for 2–15% of all central nervous system (CNS) tumors. Most intraspinal tumors are benign, and about 40% of them occur intradurally, for which early surgery is the preferred treatment. Laminectomy w
Externí odkaz:
https://doaj.org/article/7300a27a11964beb99839c20b269ac5f
Publikováno v:
Cancers, Vol 15, Iss 1, p 264 (2022)
Objective: To summarize the function and efficacy of immunotherapy as an adjunctive therapy in the treatment of advanced chordoma. Methods: Literature search was conducted by two reviewers independently. Case reports, case series and clinical trials
Externí odkaz:
https://doaj.org/article/0c8c38b748074b5f9be39adaadc5d777
Autor:
Zhaoyu Chen, Zhilong Shen, Xiang Wang, Pengru Wang, Xiaofei Zhu, Jiefu Fan, Bo Li, Wei Xu, Jianru Xiao
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 23, p 6901 (2022)
Due to limited investigations about efficacy of tyrosine kinase inhibitors (TKIs) plus immune-checkpoint inhibitors (ICIs) versus TKIs alone, and effects of durations of bone modifying agents (BMAs) on the survival of patients with hepatocellular car
Externí odkaz:
https://doaj.org/article/d9beeb1cf11d4656b40de6cf90e79ceb